Selecting antihypertensive therapy in the pregnant woman with diabetes mellitus

References

• Klein B EK, Klein R, Moss S E. Blood pressure in a population of diabetic persons diagnosed after 30 years of age. Am J Public Health 1984; 74: 336–339
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Hypertension in pregnancy. American College of Obstetricians and Gynecologists, Washington, DC 1996
   Google Scholar
• Sibai B M. Treatment of hypertension in pregnant women. N Engl J Med 1996; 335: 257–265
   PubMed Web of Science ®Google Scholar
• Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413–2436
   PubMed Web of Science ®Google Scholar
• Sibai B M, Anderson G D. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 1986; 67: 517–522
   PubMed Web of Science ®Google Scholar
• Kincaid‐Smith P, Bullen M, Mills J. Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J 1966; 1: 274–276
   PubMedGoogle Scholar
• Sibai B M, Mabie W C, Shamsa F, Villar M A, Anderson G D. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990; 162: 960–967
   PubMed Web of Science ®Google Scholar
• Pickles C J, Pipkin F B, Symonds E M. A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol 1992; 99: 964–968
   PubMedGoogle Scholar
• Curb J D, Pressel S L, Cutler J A, Savage P J, Applegate W B, Black H, Camel G, Davis B R, Frost P H, Gonzales N, Guthrie G, Oberman A, Rutan G H, Stamler J. Effect of diuretic‐based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276: 1886–1892
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997; 20: S5–S13
   Google Scholar
• Cooper M E. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352: 213–219
   PubMed Web of Science ®Google Scholar
• Zatz R, Dunn B R, Meyer T W, Anderson S, Rennke H G, Brenner B M. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925–1930
   PubMed Web of Science ®Google Scholar
• Mauer S M, Steffes M W, Ellis E N, Sutherland D E, Brown D M, Goetz F C. Structural‐functional relationships in diabetic nephropathy. J Clin Invest 1984; 74: 1143–1155
   PubMed Web of Science ®Google Scholar
• Lewis E J, Hunsicker L G, Bain R P, Rohde R D. The effects of angiotensin‐converting‐enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–1462
   PubMed Web of Science ®Google Scholar
• Rosa F W, Bosco L A, Graham C F, Milstein J B, Dreis M, Creamer J. Neonatal anuria with maternal angiotensin‐converting enzyme inhibition. Obstet Gynecol 1989; 74: 371–374
   PubMed Web of Science ®Google Scholar
• Barr M, Cohen M M. ACE inhibitor fetopathy and hypocalvaria: the kidney‐skull connection. Teratology 1991; 44: 485–495
   PubMedGoogle Scholar
• Harewood W J, Phippard A F, Duggin G G, Horvath J S, Tiller D J. Fetotoxicity of angiotensin‐converting enzyme inhibition in primate pregnancy: a prospective, placebo‐controlled study in baboons (Papio hamadryas). Am J Obstet Gynecol 1994; 171: 633–642
   PubMedGoogle Scholar
• Pipkin F B, Symonds E M, Turner S R. The effect of captopril (SQ14225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol 1982; 323: 415–422
   Google Scholar
• Mastrobattista J M. Angiotensin converting enzyme inhibitors in pregnancy. Semin Perinatol 1997; 21: 124–134
   Google Scholar
• Centers for Disease Control and Prevention. Postmarketing surveil‐lance for angiotensin‐converting enzyme inhibitor use during the first trimester of pregnancy—United States, Canada, and Israel, 1987–1995. Morb Mortal Wkly Rep 1997; 46: 240–242
   Google Scholar
• American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994; 93: 137–150
   PubMed Web of Science ®Google Scholar
• Slataper R, Vicknair N, Sadler R, Bakris G L. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993; 153: 973–980
   PubMed Web of Science ®Google Scholar
• O'Donnell M J, Rowe B R, Lawson N, Horton A, Gyde O H, Barnett A H. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomized, double‐blind study. J Hum Hypertens 1993; 7: 333–339
   Google Scholar
• Ruggenenti P, Mosconi L, Bianchi L, Cortesi L, Campana M, Pagani G, Mecca G, Remuzz G. Long‐term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non‐insulin‐dependent diabetic patients. Am J Kidney Dis 1994; 24: 753–761
   PubMed Web of Science ®Google Scholar
• Demarie B K, Bakris G L. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 113: 987–988
   PubMed Web of Science ®Google Scholar
• Bakris G L, Copley J B, Vicknair N, Sadler R, Leurgans S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM‐associated nephropathy. Kidney Int 1996; 50: 1641–1650
   PubMed Web of Science ®Google Scholar
• Guasch A, Parham M, Zayas C F, Campbell O, Nzerue C, Macon E. Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African‐Americans with noninsulin‐dependent diabetes mellitus and nephropathy. J Am Soc Nephrol 1997; 8: 793–798
   PubMed Web of Science ®Google Scholar
• Estacio R O, Jeffers B W, Hiatt W R, Biggerstaff S L, Gifford N, Schrier R W. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension. N Engl J Med 1998; 338: 645–652
   PubMed Web of Science ®Google Scholar
• Poulter N R. Calcium antagonists and the diabetic patient: a response to recent controversies. Am J Cardiol 1998; 82: 40R–41R
   Google Scholar
• Magee L A, Schick B, Donnenfeld A E, Sage S R, Conover B, Cook L, McElhatton P R, Schmidt M A, Koren G. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996; 174: 823–828
   PubMed Web of Science ®Google Scholar
• Belfort M A, Anthony J, Buccimazza A, Davey D A. Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension. Am J Obstet Gynecol 1990; 75: 970–974
   Google Scholar